{"schema_version":"secwatch.filing_event.v1","accession":"0000877860-23-000110","form_type":"8-K","ticker":"NHI","cik":"0000877860","company_name":"NATIONAL HEALTH INVESTORS INC","filed_at":"2023-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.218314+00:00","generated_at":"2026-06-08T18:30:54.810014+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"NHI Q3 Normalized FFO $1.08; revises 2023 guidance; occupancy improves","bullets":["Net income per diluted share $0.68 (Q3 2023) vs $0.78 prior year; Normalized FFO $1.08 vs $1.06.","Revised 2023 Normalized FFO guidance to $4.28-$4.31 (from $4.31-$4.35); Normalized FAD raised to $186M-$187.6M.","Occupancy improved: Bickford 84.8% (Sep vs 84.7% prior year), SHOP 81.2% (vs 76.6%).","Net debt/EBITDA 4.4x; $205M drawn on $700M revolver; $50M private notes repaid.","Portfolio: $25M mezzanine loan amended at 10%; sold three ALFs for $5.4M cash plus $1.6M financing."],"urls":{"canonical":"https://secwatch.observer/filing/0000877860-23-000110","json":"https://secwatch.observer/filing/0000877860-23-000110.json","markdown":"https://secwatch.observer/filing/0000877860-23-000110.md","text":"https://secwatch.observer/filing/0000877860-23-000110.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/877860/000087786023000110/0000877860-23-000110-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/877860/000087786023000110/nhi-20231107.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T18:30:54.810014+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4b1e05970ddafcc588107cccfdcb3f3eef4622cc","claim":"NATIONAL HEALTH INVESTORS INC reported the three and nine months ended September 30, 2023 results: net income Net income attributable to common stockholders per diluted common share for the three months ended September 30, 2023 wa, EPS $0.68. Guidance lowered.","evidence_excerpt":"NHI Announces Third Quarter 2023 Results MURFREESBORO, Tenn. – (November 7, 2023) National Health Investors, Inc. (NYSE:NHI) announced today its results for the three and nine months ended September 30, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/877860/000087786023000110/0000877860-23-000110-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three and nine months ended September 30, 2023"},{"label":"Net income","value":"Net income attributable to common stockholders per diluted common share for the three months ended September 30, 2023 wa"},{"label":"EPS","value":"$0.68"},{"label":"Guidance","value":"lowered"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}